-
2
-
-
84857017872
-
Epidemiology of invasive cutaneous melanoma
-
MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol. 2009;20(suppl 6): vi1-vi7.
-
(2009)
Ann Oncol.
, vol.20
, Issue.SUPPL. 6
-
-
MacKie, R.M.1
Hauschild, A.2
Eggermont, A.M.3
-
3
-
-
84857660324
-
Therapy for metastatic melanoma: The past, present, and future
-
Finn L, Markovic SN, Joseph RW. Therapy for metastatic melanoma: the past, present, and future. BMC Med. 2012;10: 23.
-
(2012)
BMC Med
, vol.10
, pp. 23
-
-
Finn, L.1
Markovic, S.N.2
Joseph, R.W.3
-
4
-
-
84863116743
-
Survival in braf v600-mutant advanced melanoma treated with vemurafenib
-
Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;336: 707-714.
-
(2012)
N Engl J Med.
, vol.336
, pp. 707-714
-
-
Sosman, J.A.1
Kim, K.B.2
Schuchter, L.3
-
5
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363: 711-723.
-
(2010)
N Engl J Med.
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
-
8
-
-
0025988354
-
Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma
-
Michelot JM, Moreau MF, Labarre PG, et al. Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J Nucl Med. 1991;32: 1573-1580.
-
(1991)
J Nucl Med.
, vol.32
, pp. 1573-1580
-
-
Michelot, J.M.1
Moreau, M.F.2
Labarre, P.G.3
-
9
-
-
0027317379
-
Phase ii scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-n-(2-diethylaminoethyl 4-iodobenzamide)
-
Michelot JM, Moreau MF, Veyre AJ, et al. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2- diethylaminoethyl 4-iodobenzamide). J Nucl Med. 1993;34: 1260-1266.
-
(1993)
J Nucl Med.
, vol.34
, pp. 1260-1266
-
-
Michelot, J.M.1
Moreau, M.F.2
Veyre, A.J.3
-
10
-
-
0032920303
-
Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting
-
Labarre P, Papon J, Moreau MF, Moins N, Veyre A, Madelmont JC. Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting. Eur J Nucl Med. 1999;26: 494-498.
-
(1999)
Eur J Nucl Med.
, vol.26
, pp. 494-498
-
-
Labarre, P.1
Papon, J.2
Moreau, M.F.3
Moins, N.4
Veyre, A.5
Madelmont, J.C.6
-
11
-
-
18644369115
-
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: A potential imaging agent for cutaneous melanoma staging
-
123I-N-(2- diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. Eur J Nucl Med Mol Imaging. 2002;29: 1478-1484.
-
(2002)
Eur J Nucl Med Mol Imaging.
, vol.29
, pp. 1478-1484
-
-
Moins, N.1
D'Incan, M.2
Bonafous, J.3
-
12
-
-
0029144657
-
Synthesis, radiolabeling, and preliminary evaluation in mice of some (n-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents
-
Moreau MF, Michelot J, Papon J, et al. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents. Nucl Med Biol. 1995;22: 737-747.
-
(1995)
Nucl Med Biol.
, vol.22
, pp. 737-747
-
-
Moreau, M.F.1
Michelot, J.2
Papon, J.3
-
14
-
-
58149190350
-
Role of pet in the initial staging of cutaneous malignant melanoma: Systematic review
-
Krug B, Crott R, Lonneux M, Baurain JF, Pirson AS, Vander Borght T. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review. Radiology. 2008;249: 836-844.
-
(2008)
Radiology.
, vol.249
, pp. 836-844
-
-
Krug, B.1
Crott, R.2
Lonneux, M.3
Baurain, J.F.4
Pirson, A.S.5
Vander Borght, T.6
-
15
-
-
84863403429
-
Cost-effectiveness of adding fdg-pet or ct to the diagnostic work-up of patients with stage iii melanoma
-
Bastiaannet E, Uyl-de Groot CA, Brouwers AH, et al. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg. 2012;255: 771-776.
-
(2012)
Ann Surg.
, vol.255
, pp. 771-776
-
-
Bastiaannet, E.1
Uyl-De Groot, C.A.2
Brouwers, A.H.3
-
17
-
-
77950361631
-
18F-mel050, a selective probe for melanin with predominantly renal clearance
-
18F-MEL050, a selective probe for melanin with predominantly renal clearance. J Nucl Med. 2010;51: 441-447.
-
(2010)
J Nucl Med.
, vol.51
, pp. 441-447
-
-
Denoyer, D.1
Greguric, I.2
Roselt, P.3
-
19
-
-
84901389050
-
18F mel050) using pet/ct in patients with metastatic melanoma
-
Identifier, NCT01620749. Published May 27, 2012. Updated June 14, 2012. Accessed October 30
-
18F MEL050) using PET/CT in patients with metastatic melanoma. ClinicalTrials.gov Web site. Identifier, NCT01620749. http://clinicaltrials.gov/ct2/show/study/NCT01620749. Published May 27, 2012. Updated June 14, 2012. Accessed October 30, 2013.
-
(2013)
ClinicalTrials.Gov Web Site
-
-
-
20
-
-
0022498646
-
Fine needle aspiration biopsy of metastatic melanoma: A morphologic analysis of 174 cases
-
Perry MD, Gore M, Seigler HF, Johnston WW. Fine needle aspiration biopsy of metastatic melanoma: a morphologic analysis of 174 cases. Acta Cytol. 1986;30: 385-396.
-
(1986)
Acta Cytol.
, vol.30
, pp. 385-396
-
-
Perry, M.D.1
Gore, M.2
Seigler, H.F.3
Johnston, W.W.4
-
21
-
-
0036844163
-
Cytomorphologic features of fineneedle aspiration of metastatic and recurrent melanoma
-
Saqi A, McGrath CM, Skovronsky D, Yu GH. Cytomorphologic features of fineneedle aspiration of metastatic and recurrent melanoma. Diagn Cytopathol. 2002; 27: 286-290.
-
(2002)
Diagn Cytopathol.
, vol.27
, pp. 286-290
-
-
Saqi, A.1
McGrath, C.M.2
Skovronsky, D.3
Yu, G.H.4
-
22
-
-
33745914962
-
Improved detection of metastatic melanoma by t2-weighted imaging
-
Gaviani P, Mullins ME, Braga TA, et al. Improved detection of metastatic melanoma by T2-weighted imaging. AJNR. 2006;27: 605-608.
-
(2006)
AJNR.
, vol.27
, pp. 605-608
-
-
Gaviani, P.1
Mullins, M.E.2
Braga, T.A.3
-
23
-
-
17144423534
-
Detectability of liver metastases in malignant melanoma: Prospective comparison of magnetic resonance imaging and positron emission tomography
-
Ghanem N, Altehoefer C, Högerle S, et al. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol. 2005;54: 264-270.
-
(2005)
Eur J Radiol.
, vol.54
, pp. 264-270
-
-
Ghanem, N.1
Altehoefer, C.2
Högerle, S.3
-
24
-
-
78650319332
-
Molecular probes for malignant melanoma imaging
-
Ren G, Pan Y, Cheng Z. Molecular probes for malignant melanoma imaging. Curr Pharm Biotechnol. 2010;11: 590-602.
-
(2010)
Curr Pharm Biotechnol.
, vol.11
, pp. 590-602
-
-
Ren, G.1
Pan, Y.2
Cheng, Z.3
-
26
-
-
80054696854
-
177lu, 166ho, and 153sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma
-
177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma. Cancer Biother Radiopharm. 2011;26: 547-556.
-
(2011)
Cancer Biother Radiopharm.
, vol.26
, pp. 547-556
-
-
Ballard, B.1
Jiang, Z.2
Soll, C.E.3
-
27
-
-
77952844046
-
131i-labeled benzamide for targeted radiotherapy of metastatic melanoma
-
131I-labeled benzamide for targeted radiotherapy of metastatic melanoma. Cancer Res. 2010; 70: 4045-4053.
-
(2010)
Cancer Res.
, vol.70
, pp. 4045-4053
-
-
Joyal, J.L.1
Barrett, J.A.2
Marquis, J.C.3
|